American Bio Medica's rapid drug screen cleared by FDA:
This article was originally published in Clinica
American Bio Medica's rapid drug screen has clearance from the FDA for marketing in the US. The one-step diagnostic test detects the presence of marijuana, cocaine, acid, amphetamines and opiates in three to five minutes. The company, based in Ancramdale, New York, says that test results correlate 100% to laboratory tests at the clinical sensitivity levels suggested by the US Substance Abuse and Mental Health Services. Administration.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.